These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31560045)

  • 1. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Abu-Sbeih H; Wang Y
    Inflamm Bowel Dis; 2020 Apr; 26(5):662-668. PubMed ID: 31560045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.
    Abu-Sbeih H; Ali FS; Wang Y
    Curr Opin Gastroenterol; 2020 Jan; 36(1):25-32. PubMed ID: 31609734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.
    Ibraheim H; Baillie S; Samaan MA; Abu-Sbeih H; Wang Y; Talley NJ; P Jones M; Powell N
    Aliment Pharmacol Ther; 2020 Nov; 52(9):1432-1452. PubMed ID: 32920854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
    Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
    Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
    Jain A; Lipson EJ; Sharfman WH; Brant SR; Lazarev MG
    World J Gastroenterol; 2017 Mar; 23(11):2023-2028. PubMed ID: 28373768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis.
    Powell N; Ibraheim H; Raine T; Speight RA; Papa S; Brain O; Green M; Samaan MA; Spain L; Yousaf N; Hunter N; Eldridge L; Pavlidis P; Irving P; Hayee B; Turajlic S; Larkin J; Lindsay JO; Gore M
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):679-697. PubMed ID: 32553146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
    Alexander JL; Ibraheim H; Sheth B; Little J; Khan MS; Richards C; Hunter N; Chauhan D; Ratnakumaran R; McHugh K; Pinato DJ; Nathan P; Choy J; Crusz SM; Furness A; Turajlic S; Pickering L; Larkin J; Teare JP; Papa S; Speight A; Sharma A; Powell N
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34233964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review.
    Collins M; Soularue E; Marthey L; Carbonnel F
    Clin Gastroenterol Hepatol; 2020 May; 18(6):1393-1403.e1. PubMed ID: 32007539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy induced enterocolitis and gastritis - What to do and when?
    Cheung VTF; Brain O
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101703. PubMed ID: 33317787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review.
    Gong Z; Wang Y
    JCO Oncol Pract; 2020 Aug; 16(8):453-461. PubMed ID: 32584703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
    Bergqvist V; Hertervig E; Gedeon P; Kopljar M; Griph H; Kinhult S; Carneiro A; Marsal J
    Cancer Immunol Immunother; 2017 May; 66(5):581-592. PubMed ID: 28204866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibitors-Induced Colitis.
    Tian Y; Abu-Sbeih H; Wang Y
    Adv Exp Med Biol; 2018; 995():151-157. PubMed ID: 30539510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.
    Prieux-Klotz C; Dior M; Damotte D; Dreanic J; Brieau B; Brezault C; Abitbol V; Chaussade S; Coriat R
    Target Oncol; 2017 Jun; 12(3):301-308. PubMed ID: 28540478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
    Shirwaikar Thomas A; Hanauer S; Wang Y
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):878-890. PubMed ID: 36270617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report.
    Holmstroem RB; Dahl EK; Helms M; Nielsen HV; Andersen JB; Bjerrum JT; Svane IM; Ellebaek E; Seidelin JB
    BMJ Open Gastroenterol; 2022 Dec; 9(1):. PubMed ID: 36581371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor-induced diarrhea and colitis: an overview.
    Zoghbi M; Burk KJ; Haroun E; Saade M; Carreras MTC
    Support Care Cancer; 2024 Sep; 32(10):680. PubMed ID: 39311981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
    Ma C; MacDonald JK; Nguyen TM; Vande Casteele N; Linggi B; Lefevre P; Wang Y; Feagan BG; Jairath V
    Dig Dis Sci; 2022 Apr; 67(4):1128-1155. PubMed ID: 33770330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis.
    Stone ML; Forster EM
    Inflamm Bowel Dis; 2021 Nov; 27(12):e147. PubMed ID: 34244730
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives.
    Dougan M
    Curr Gastroenterol Rep; 2020 Mar; 22(4):15. PubMed ID: 32185493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.